DCLK1 and pancreatic neoplasm: Several studies also indicated that downregulating DCLK1 expression or inhibiting its kinase activity leads to growth arrest of colorectal, pancreatic, and renal cancers [36,37,38] as well as decreases metastasis of colorectal and pancreatic cancers [39,40].